Jazz Pharmaceuticals plc Business Operations Contracts & Agreements
50 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Development Agreements (5)
- Distribution Agreements (7)
- Indemnification Agreements (3)
- Services Agreements (16)
- Settlement Agreements (5)
- Supply Agreements (12)
- Termination Agreements (1)
- Pharmacy Master Services Agreement, dated as of (Filed With SEC on March 1, 2023)
- License and Collaboration Agreement, dated October 18, 2022, between Jazz Pharmaceuticals Ireland Limited and Zymeworks BC Inc (Filed With SEC on December 5, 2022)
- Amendment No. 7, dated as of September 28, 2022, to Pharmacy Master Services Agreement, dated as of (Filed With SEC on November 9, 2022)
- Amendment No. 6, dated as of August 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on November 9, 2022)
- Amendment No. 1 Clinical and Commercial Manufacturing and Supply Agreement, dated as of January 18, 2018, by and between Jazz Pharmaceuticals Ireland Limited and Baxter Oncology... (Filed With SEC on November 9, 2022)
- Clinical and Commercial Manufacturing and Supply Agreement, dated as of December 22, 2010, between Celator Pharmaceuticals, Inc. and Baxter Oncology GmbH (Filed With SEC on November 9, 2022)
- Settlement Agreement, dated as of April 5, 2017, by and between Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Limited, and Roxane Laboratories, Inc., West-Ward... (Filed With SEC on November 9, 2022)
- Amendment No. 5, dated as of June 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on August 3, 2022)
- Amendment No. 4, dated as of April 18, 2022 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Filed With SEC on May 4, 2022)
- Service Agreement, dated as of May 5, 2021, by and between Chris Tovey and Jazz Pharmaceuticals UK Limited (Filed With SEC on August 3, 2021)
- Amendment No. 2, dated as of July 19, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Filed With SEC on August 3, 2021)
- Amendment No. 1, dated as of July 4, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Filed With SEC on August 3, 2021)
- Master Manufacturing Services Agreement, dated as of October 1, 2015, by and between Jazz Pharmaceuticals Ireland Limited and Patheon Pharmaceuticals Inc (Filed With SEC on February 23, 2021)
- Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution Services, Inc (Filed With SEC on August 4, 2020)
- Amendment No. 1 to Pharmacy Master Services Agreement, effective as of June 30, 2019, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution... (Filed With SEC on May 7, 2019)
- Settlement Agreement, dated as of April 4, 2019, by and among United States of America, acting through the United States Department of Justice and on behalf of the Office of... (Filed With SEC on May 7, 2019)
- Corporate Integrity Agreement, dated as of April 3, 2019, by and between Jazz Pharmaceuticals plc and the Office of Inspector General of the United States Department of Health and... (Filed With SEC on May 7, 2019)
- Amendment No. 1 Clinical and Commercial Manufacturing and Supply Agreement, dated as of January 18, 2018, by and between Jazz Pharmaceuticals Ireland Limited and Baxter Oncology... (Filed With SEC on May 8, 2018)
- Clinical and Commercial Manufacturing and Supply Agreement, dated as of December 22, 2010, between Celator Pharmaceuticals, Inc. and Baxter Oncology GmbH (Filed With SEC on February 27, 2018)
- Pharmacy Master Services Agreement (Filed With SEC on August 8, 2017)
- SETTLEMENT AGREEMENT (Filed With SEC on August 8, 2017)
- Master Manufacturing Services Agreement October 1, 2015 (Filed With SEC on February 23, 2016)
- DATED MAY 13, 2015 NOVATION AGREEMENTrelating toRoyalty Bearing Licence Agreement and Supply Agreement re Erwinia-Derived Asparaginase (Filed With SEC on August 5, 2015)
- MASTER SERVICES AGREEMENT (Filed With SEC on May 9, 2011)
- AMENDMENT NO. 1 TO THE MASTER SERVICES AGREEMENT (Filed With SEC on November 5, 2010)
- SUPPLY AGREEMENT between Jazz Pharmaceuticals, Inc., 3180 Porter Drive, Palo Alto, CA 94304 (hereinafter JAZZ PHARMACEUTICALS) and Siegfried (USA) Inc, 33 Industrial Park Road,... (Filed With SEC on May 6, 2010)
- INDEMNIFICATION AGREEMENT (Filed With SEC on July 7, 2009)
- AMENDMENT TO SETTLEMENT AGREEMENT (Filed With SEC on March 26, 2009)
- MASTER SERVICES AGREEMENT (Filed With SEC on May 15, 2008)
- ADDENDUM No. 5 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on March 31, 2008)
- ADDENDUM No. 4 TO AMENDED AND RESTATED MASTER SERVICES AGREEMENT (Filed With SEC on November 9, 2007)
- SETTLEMENT AGREEMENT I. PARTIES (Filed With SEC on July 18, 2007)
- XYREM® Manufacturing Services and Supply Agreement Between Patheon Pharmaceuticals Inc. and (Filed With SEC on May 31, 2007)
- Amendment No.2 to Sodium Gamma Hydroxybutyrate Development and Supply Agreement (Filed With SEC on May 24, 2007)
- SUPPLY AGREEMENT Between JazzPharmaceuticals, Inc. and Solvay Pharmaceuticals, Inc. for Fluvoxamine Maleate SUPPLY AGREEMENT (Filed With SEC on May 24, 2007)
- Amendment No. 1 to Sodium Gamma Hydroxybutyrate Development and Supply Agreement (Filed With SEC on May 24, 2007)
- JAZZ PHARMACEUTICALS, INC. 2007 EQUITYINCENTIVE PLAN APPROVED BY THE BOARD:MAY 1, 2007 APPROVED BY THE STOCKHOLDERS:MAY 9, 2007 TERMINATION DATE: APRIL 30, 2017 (Filed With SEC on May 17, 2007)
- INDEMNIFICATION AGREEMENT (Filed With SEC on May 17, 2007)
- Amendment No. 2 to Sodium Gamma Hydroxybutyrate Development and Supply Agreement (Filed With SEC on April 20, 2007)
- XYREM® Manufacturing Services and Supply Agreement Between Patheon Pharmaceuticals Inc. and (Filed With SEC on March 27, 2007)